France - Laboratory reagents
For more information and to make a bid you will need to go to the third party website.
Details
Provided by
- Opportunity closing date
- 08 April 2019
- Opportunity publication date
- 27 February 2019
- Category
- 33696500, , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , ,
- Value of contract
- £5m-50m
- Your guide to exporting
Description
Acetone - xylene. The framework agreement is concluded with a minimum and a maximum. Laboratory animals The Framework Agreement is concluded with a minimum and a maximum Miscellaneous alcohols (lost packaging) the Framework Agreement is concluded with a minimum and a maximum Alcohols for Testing the Framework Agreement is concluded, with a minimum and a maximum Acetic Acid The Framework Agreement is concluded with a minimum and a maximum Histaminemia The Framework Agreement is concluded with a minimum and a maximum Anti-epsteine antibody Barr The Framework Agreement is concluded with a minimum and a maximum Rabbit Complement The Framework Agreement is concluded with a minimum and a maximum Research of Anti-hla class i antibodies by Microlymphocytotoxicite technique The AgreementFramework is concluded with a minimum and a maximum Tumour marker antibodies The Framework Agreement is concluded with a minimum and a maximum Monoclonal antibody for viral diagnosis The Framework Agreement is concluded with a minimum and a maximum Monoclonal antibodies and tumour markers in Paraffin The Framework Agreement is concluded with a minimum and a maximum Flow cytometry: smd diagnosis (red Score-1) The Framework Agreement is concluded with a minimum and a maximum Flow cytometry: smd diagnosis (red Score-2) The Framework Agreement is concluded with a minimum and a maximum Flow cytometry: Hpn-1 hematology exploration The Framework Agreement is concluded with a minimum and a maximum Flow cytometry: Platelet exploration (Igp) The Framework Agreement is concluded with a minimum and maximum Monoclonal and Polyclonal antibodies The Framework Agreement is concluded with a minimum and maximum Monoclonal and polyclonal antibodies - demasking solutions and buffers The Framework Agreement is concluded with a minimum and maximum Monoclonal and polyclonal antibodies for Immunolabelling The Framework Agreement is concluded with a minimum and maximum Flow cytometry: Cell permeation The Framework Agreement is concluded with a minimum and a maximum Antibody for paraffin immunolabeling of Colonic tumors The Framework Agreement is concluded with a minimum and a maximum Dilution buffer for Antibody The Framework Agreement is concluded with a minimum and a maximum Flow cytometry: Slpt hematology exploration Slpt The Framework Agreement is concluded with a minimum and a maximum Anti-vhe antibody Igg and ANTI-VHE Igm The Framework Agreement is concluded with a minimum and a maximum Anti-htlv antibody 1 and 2 the agreement-framework is concluded with a minimum and a maximum Lysis buffer for phenotyping in blood flow cytometry Total The Framework Agreement is concluded with a minimum and a maximum Determination of endotoxins by chromogenic and kinetic method by limulus Amebocyte lysate (semi-automatic (kinetic) test) the agree-The Framework Agreement is concluded with a minimum and a maximum Internal quality control as part of the Accreditation of Mycoplasma The Framework Agreement is concluded with a minimum and a maximum Indelible dyes for surgical parts (vials) the agreement -The Framework Agreement is concluded with a minimum and a maximum Monoclonal antibodies for the study of lymphocyte populations in flow cytometry The Framework Agreement is concluded with a minimum and a maximum Sheep Hematia The Framework Agreement is concluded with a minimum and a maximum Monoclonal antibodies for respiratory viruses (Mixture of monoclonal antibodies labelled FITC Grippe A-B, parainfluenza 1-2-3, Adenovirus x 80 tests) the framework agreement is concluded with a minimum and maximum monoclonal antibodies for respiratory viruses (Anti Respiratory Syncytial Viruses, marked FITC x 650 tests - anti Influenza A, marked FITC x 650 tests - anti Influenza B, marked FITC x 650 tests - anti Parainfluenza 1, marked FITC x 650 tests - anti Parainfluenza 2, marked FITC x 650 tests - anti Parainfluenza 3, marked FITC x 650 tests) the framework agreement is concluded with a minimum and maximum purified antibodies brands alkaline phosphatase, Streptavidin The Framework Agreement is concluded with a minimum and a maximum Antigenomy P24 The Framework Agreement is concluded with a minimum and a maximum Antitoxoplasmic antibodies by Immunoblot The Framework Agreement is concluded with a minimum and a maximum Anti-Ia2 Antibodies The Framework Agreement is concluded with a minimum and a maximum Anti-Ia2 AntibodiesPhospholipase-A2 receptor The Framework Agreement is concluded with a minimum and a maximum Anti-Endomysium Auto-antibody The Framework Agreement is concluded with a minimum and a maximum Anti-Intrinsic Factor Auto-antibody The Framework Agreement is concluded with a minimum and a maximum Basal Membrane Auto-antibody Glomerular The AgreementFramework is concluded with a minimum and a maximum Anti-Mitochondria Auto-antibodies The Framework Agreement is concluded with a minimum and a maximum Anti-actin antibodies by Immunofluorescence The Framework Agreement is concluded with a minimum and a maximum Anti-Nuclear Auto-antibodies The Framework Agreement is concluded with a minimum and a maximum Auto-Anti-Skin Antibody Framework Agreement is concluded with a minimum and a maximum Anti-Gad Auto-antibody Framework Agreement is concluded with a minimum and a maximum Auto-antibody in Hepatology Framework Agreement is concluded with a minimum and a maximum Detection of Igg auto-antibodies directed against myeloperoxidase antigens (mpo) proteinase 3 (Pr3) and glomerular basal membrane (alpha3 collagen chain iv) in Human serum The Framework Agreement is concluded with a minimum and a maximum Antibodies for the study of surface immunoglobulins The Framework Agreement is concluded with a minimum and a maximum Auto-antibodies of Polynuclear cytoplasmas The Framework Agreement is concluded with a minimum and a maximum Non-specific Auto-antibodies of Mouse Organs The AgreementFramework is concluded with a minimum and a maximum Auto-antibody in neurology by indirect immunofluorescence The Framework Agreement is concluded with a minimum and a maximum Non-specific organ autoantibodies The Framework Agreement is concluded with a minimum and a maximum Anti-Surrenal antibodies The Framework Agreement is concluded with a minimum and a maximum Anti-skin Splittee The Framework Agreement is concluded with a minimum and a maximum Bacteriology: antibiotic strips for determining the minimum inhibitory concentration (C.M.I.) The Framework Agreement is concluded with a minimum and a maximum Hematology: Molecular Biology The Framework Agreement is concluded with a minimum and a maximum Bacteriology: Molecular Biology The Framework Agreement is concluded with a minimum and a maximum Hospital Hygiene: Bacteriological control of Endoscopes The Framework Agreement is concluded with a minimum and a maximum Bacteriology: discs and distributors for Antibiograms The Framework Agreement is concluded with a minimum and a maximum Bacteriology: selective gelose for enterococci resistant to Vancomycin The Framework Agreement is concluded with a minimum and a maximum Bacteriology: specific gelose for antibiotic susceptibility testing of enterobacteria Blse The Framework Agreement is concluded with a minimum and a maximum Bacteriology: detection of the Gdh Antigen The Framework Agreement is concluded with a minimum and a maximum Bacteriology: gelose ready for use The Framework Agreement is concluded with a minimum and a maximum Bacteriology: B The Framework Agreement is concluded with a minimum and a maximum Bacteriology: gelose ready for use for antibiotic susceptibility testing The Framework Agreement is concluded with a minimum and a maximum Bacteriology: chromogenic gelose for Meti staphylococcus screening.A The Framework Agreement is concluded with a minimum and a maximum Bacteriology: gelose ready for use FOR Coproculture The Framework Agreement is concluded with a minimum and a maximum Bacteriology: selective gelose ready for use the Framework Agreement is concluded with a minimum and a maximum Bacteriology: Ready-to-use gelose FOR Salmonella The Framework Agreement is concluded with a minimum and a maximum Bacteriology: chromogenic gelose for Aureus staphylococcus The Framework Agreement is concluded with a minimum and a maximum Bacteriology: culture medium and reagents for conservation The Framework Agreement is concluded with a minimum and a maximum Bacteriology: chromogenic gelose for identification of urinary germs The Framework Agreement is concluded with a minimum and a maximum Bacteriology: Bacteriological Identification Biochemical Test The Framework Agreement is concluded with a minimum and a maximum Bacteriology: culture medium in hospital hygiene (Baird Parker Agar - surface microbiology agar (countact type)) the Framework Agreement is concluded with a minimum and a maximum Bacteriology: culture medium in hospital hygiene (peptone water: - tubes 9 ml - vials 225 ml - broth Cervelle Heart 10 ml - broth selenite cystine 20 ml - broth Schaedler 10 ml - broth Trypticase-Soja 10 ml - broth Rappaport Vassiliadis 10 ml) the framework agreement is concluded with a minimum and a maximum Bacteriology: chromogenic gelose for wheat-producing enterobacteria and Acinetobacteria The Framework Agreement is concluded with a minimum and a maximum Bacterial Typing The Framework Agreement is concluded with a minimum and a maximum Bacteriology: cmi by Microdilution The Framework Agreement is concluded with a minimum and maximum Agglutination Test for identification of Aureus staphylococcus The Framework Agreement is concluded with a minimum and a maximum Hygienic: microbiological control of Food The Framework Agreement is concluded with a minimum and a maximum Bacteriology: Microbiological control of water The Framework Agreement is concluded with a minimum and a maximum Bacteriology: RESEARCH FOR Pneumococcal urinary antigens The Framework Agreement is concluded with a minimum and a maximum Bacteriology: RESEARCH FOR Legionella urinary antigens The Framework Agreement is concluded with a minimum and a maximum Bacteriology: medium and reagents intended for the detection of bacteria of difficult culture The Framework Agreement is concluded with a minimum and a maximum Bacteriology: antiserum for Hemophilus The Framework Agreement is concluded with a minimum and a maximum Culture medium for legionella in Hygiene The Framework Agreement is concluded with a minimum and a maximum Diagnosis of tuberculosis The Framework Agreement is concluded with a minimum and a maximum Diagnosis of pertussis The AgreementFramework is concluded with a minimum and a maximum Meningococcal Research The Framework Agreement is concluded with a minimum and a maximum Enrichment Medium for Vancomycin-resistant Enterococcus The Framework Agreement is concluded with a minimum and a maximum Bacteriology: Rapid detection of clostridium difficile toxin a and b The Framework Agreement is concluded with a minimum and maximum Bacteriology: Oxidase detection The Framework Agreement is concluded with a minimum and maximum Bacteriology: ETHANOL 70% The Framework Agreement is concluded with a minimum and a maximum Bacteriology: solid media for the cultivation of Mycobacteria The Framework Agreement is concluded with a minimum and a maximum Bacteriology: PCR Whipple The Framework Agreement is concluded with a minimum and a maximum Bacteriology: Carbapenemase research The Framework Agreement is concluded with a minimum and a maximum Bacteriology: organic solvent solution for Maldi-Tof The Framework Agreement is concluded with a minimum and a maximum Bacteriology: reagents for Co2 culture, anaerobia and Microaerophilia The Framework Agreement is concluded with a minimum and a maximum Hygiene: Lactobacilli research in food products The Framework Agreement is concluded with a minimum and a maximum Bacteriology: rapid diagnosis of mycobacteria of the Tuberculosis complex The Framework Agreement is concluded with a minimum and a maximum Bacteriology: rapid diagnosis of Campylobacter The Framework Agreement is concluded with a minimum and a maximum Hygiene: quantitative control of Legionella The Framework Agreement is concluded with a minimum and a maximum Bacteriology: reactive for shigella, salmonella, e.coli, streptococci group b, Meningococcus The Framework Agreement is concluded with a minimum and a maximum Virology: research cmv Hhv6,7,8 The Framework Agreement is concluded with a minimum and a maximum Specific media for germs research The Framework Agreement is concluded with a minimum and a maximum Specific media for germs research Anaerobia The Framework Agreement is concluded with a minimum and a maximum Bacteriology: culture supplement and enrichment medium The Framework Agreement is concluded with a minimum and a maximum Research by real time pcr of herpes viruses The Framework Agreement is concluded with a minimum and a maximum Molecular biology: disinfection solution for Paillasses The Framework Agreement is concluded with a minimum and a maximum Monoclonal antibodies The Framework Agreement is concluded with a minimum and a maximum Thermal antibody for lung cancer The Framework Agreement is concluded with a minimum and a maximum molecular biology: Sequence product purification The Framework Agreement is concluded with a minimum and a maximum Molecular biology: basic reagents and preparation of buffers The Framework Agreement is concluded with a minimum and a maximum Molecular biology: oligonucleotides of unamended synthesis The Framework Agreement is concluded with a minimum and a maximum Molecular biology: Modified synthetic oligonucleotides and probes for real-time pcr The Framework Agreement is concluded with a minimum and a maximum Molecular Biology: Miscellaneous REACTIVES The Framework Agreement is concluded with a minimum and a maximum Molecular Biology: The Framework Agreement is concluded with a minimum and a maximum Molecular Biology: dna human polyomavirus jc/bk by Pcr The Framework Agreement is concluded with a minimum and a maximum Molecular Biology: supply of reagents for methylation analysis (fingerprint disease) the framework agreement is concluded with a minimum and a maximum Molecular biology: supply of reagents for DNA extraction from whole blood The framework agreement is concluded with a minimum and a maximum Molecular biology: reagents for analysis of fusion transcripts The framework agreement is concluded with a minimum and a maximum molecular biology: Reagents for Clonality Analysis The Framework Agreement is concluded with a minimum and a maximum Molecular Biology: Agarose The Framework Agreement is concluded with a minimum and a maximum Molecular Biology: various reagents for southern blots, northern blots and Pcr The Framework Agreement is concluded with a minimum and a maximum Molecular Biology: various Nucleic acid extraction reagents The Framework Agreement is concluded with a minimum and a maximum Molecular Biology: reagents for the detection of constitutional changes by Mlpa technique The Framework Agreement is concluded with a minimum and maximum Molecular Biology: Nonphenolic NUCLEIC Acid Extraction Systems (Erythrocyte Lysis Buffer C253 x 1,000 ml ready for use - Tissue Lysis Buffer Kit (50 to 200 ml) ready for use)) the Framework Agreement is concluded with a minimum and maximum Molecular Biology: NUCLEIC Acid Non-Phenolic Extraction Systems (Blood Arn Extraction Kit (max 1.5 ml) x 50 tests - Blood DNA Extraction Kit x 50 tests) the framework agreement is concluded with a minimum and maximum Molecular Biology: Non-Phenolic Nuclear Acid Extraction Systems from Human Genomic Blood The framework agreement is concluded with a minimum and maximum Molecular Biology: reagents and consumables for human genomic DNA pan pan chip (Cgh-Array) The Framework Agreement is concluded with a minimum and maximum number of free light chains kappa and lambda in blood and in Urine (validated adaptation for quantitative assay on prospective bn PLC, Siemens) The Framework Agreement is concluded with a minimum and a maximum Aerosol for rapid cryotomy in a cylinder The Framework Agreement is concluded with a minimum and a maximum Clarifying for Paraffin The Framework Agreement is concluded with a minimum and a maximum Clarifying for node research in Curages The AgreementFramework is concluded with a minimum and maximum Dyes in Medical Biology and Pathology The Framework Agreement is concluded with a minimum and maximum Dyes for Parasitic and Fungal Immunology The Framework Agreement is concluded with a minimum and a maximum Freezer Transport Registrar The Framework Agreement is concluded with a minimum and a maximum Cytology: Microscopic READING The Framework Agreement is concluded with a minimum and maximum Cytology: mpo (myeloperoxidase) staining kit the framework agreement is concluded with a minimum and a maximum Narcotic drugs The framework agreement is concluded with a minimum and a maximum Quality control icp Ms The framework agreement is concluded with a minimum and a maximum Quality control for flow cytometry on whole blood Stabilized The framework agreement is concluded with a minimum and a maximum Flow cytometry: Quality control The framework agreement is concluded with a minimum and a maximum Cell culture: Cell separation tubes for Lymphocytes The Framework Agreement is concluded with a minimum and a maximum Cell culture additives for cytogenetic study of Llc The Framework Agreement is concluded with a minimum and a maximum Cell culture media for cytogenetic study The Framework Agreement is concluded with a minimum and a maximum Cell culture additives for cytogenetic study The Framework Agreement is concluded with a minimum and a maximum Cell culture medium ready for use for cytogenetic study The Framework Agreement is concluded with a minimum and a maximum Molecular biology: supply of reagents for analysis of triplet expansion mutations The Framework Agreement is concluded with a minimum and a maximum Cell culture: synthetic medium for medically assisted procreation The Framework Agreement is concluded with a minimum and a maximum Cell culture: synthetic medium for medically assisted procreation (medium for human re-implantation: Mandatory ministerial certificate: Single culture medium with 10% hsa (bovine albumin serum) embryo tested continuously ensuring all nutritional needs of the human embryo from J1 to the blastocyst stage in vials < or equal to 10 ml) The Framework Agreement is concluded with a minimum and a maximum Cell culture: synthetic medium for medically assisted procreation (Medium for human reimplantation: mandatory ministerial certificate: HSA (human serum albumin) measured at 1 g (5 ml bottle)) the framework agreement is concluded with a minimum and a maximum Cell culture: Sperm separation medium for medically assisted procreation The Framework Agreement is concluded with a minimum and maximum Detection and typing of antibodies Antispermatozoa The Framework Agreement is concluded with a minimum and a maximum Sperm vitality determination kit The Framework Agreement is concluded with a minimum and a maximum Reagent for leukocyte detection in the semen The Framework Agreement is concluded with a minimum and a maximum Cell culture: Media and Reagents The Framework Agreement is concluded with a minimum and a maximum Sperm freezing medium The Framework Agreement is concluded with a minimum and a maximum Cell culture: slow-down medium for sperm in medical assistance to procreation The Framework Agreement is concluded with a minimum and a maximum Cell culture: media and reagents (rpmi 1640 without L.Glutamine (1 X) with Na Hco3 and phenol red (without hepatic) in 500 ml - iMD, Dulbecco medium Modified according to Iscove (1x), liquid with L-Glutamine, 25 mm hepatic, in 500 ml B36 - Penicillin-Streptomycin solution liquid 10 000 U/Ml Peni 10 000 μG/Ml Strepto, in 100 ml - pSF antibiotic-antimycotic 100x under 20 ml) the framework agreement is concluded with a minimum and maximum Cell culture: Oocyte Decorating Medium The Framework Agreement is concluded with a minimum and maximum Embryo sterile paraffin oil tested in Amp The Framework Agreement is concluded with a minimum and maximum Cell Culture: media and reagents (imdm with Glutamax x 500 ml - Dulbecco medium modified according to iscove (imdm) with L-Glutamine, 25 mm hepes, without sodium bicarbonate powder per 1 litre - D-PBS Dubelcco buffer without Ca, Mg, Na2co3, in 100 ml) the framework agreement is concluded with a minimum and maximum Cell culture: media and reagents (L.Glutamine solution at 200 mm (100 x), in 100 ml - mEM Earle without L.Glutamine (1x) with Na Hco3 and phenol red, without hepatic, in 500 ml - trypsin-Edta 0.05% (1x), phenol red, 100 ml) the framework agreement is concluded with a minimum and maximum Cell culture: freezing and thawing media for embryos of human products in medical assistance to procreation The framework agreement is concluded with a minimum and maximum Cell culture: media and reagents (rpmi 1640 without L.Glutamine with 25 mmol hep, in 500 ml - bovine albumin BSA fraction V 7.5%, in 100 ml - fetal calf serum SVF in 500 ml) the framework agreement is concluded with a minimum and maximum Universal medium without phenol red with antibiotic for medically assisted procreation The framework agreement is concluded with a minimum and maximum Cell cultures: other media and reagents The framework agreement is concluded with a minimum and maximum Cell culture: Fetal calf serum for Toxoplasma cultures The Framework Agreement is concluded with a minimum and a maximum Cell culture: Fetal calf serum for cytogenetic study The Framework Agreement is concluded with a minimum and a maximum Cell culture: human serum abosted in cytogenetics The Framework Agreement is concluded with a minimum and a maximum Histocompatibility: The Framework Agreement is concluded with a minimum and a maximum Determination of vitamins B6, B1, A and e doses in Hplc The Framework Agreement is concluded with a minimum and a maximum Calibration and control reagents for the hplc dosage of vitamin c and Mycophenolate The Framework Agreement is concluded with a minimum and a maximum Bubbling diseases - elisa technique (Anti BP 180 of the Pemphigoid bullosa box of 48 wells or 24 tests - anti BP 230 of the Pemphigoïde bullosa box of 48 wells or 24 tests - anti desmogleine-1 box of 48 wells or 24 tests - anti desmogleine-3 of the pemphigus box of 48 wells or 24 tests) the framework agreement is concluded with a minimum and maximum Bullous diseases - elisa technique (anti collagen antibody VII box of 48 wells) the agreementThe Framework Agreement is concluded with a minimum and a maximum Hemochromatosis gene study The Framework Agreement is concluded with a minimum and a maximum Mediterranean fever gene study The Framework Agreement is concluded with a minimum and a maximum Exploration of the three ways to activate the Complement The AgreementFramework is concluded with a minimum and a maximum Ready-to-use Fixers for pathological anatomy and plastic jars filled with 10% formaldehyde buffer for Biopsies The Framework Agreement is concluded with a minimum and a maximum Histological Fixator Ready-to-use The Framework Agreement is concluded with a minimum and a maximum Hemolysis: erythropoietin (Elisa technique) The Framework Agreement is concluded with a minimum and maximum Hemostasis: amidolytic dosage of factor Viii The Framework Agreement is concluded with a minimum and maximum Hemostasis: DETECTION OF antiplatelet autoantibodies (fixed on platelets and free) The Framework Agreement is concluded with a minimum and maximum Hemostasis: antigenic dosage of Antithrombin The Framework Agreement is concluded with a minimum and maximum Hemostasis: PLASMA Calibrating The Framework Agreement is concluded with a minimum and maximum Hemostasis: dosage of Adamts Activity13 (Willebrand factor protease) The Framework Agreement is concluded with a minimum and maximum Hemostasis: dosage of Factor Xiii Activity The Framework Agreement is concluded with a minimum and maximum Hemostasis: plasma deficient in factor xii (Chronometric dosage) The Framework Agreement is concluded with a minimum and a maximum Hemostasis: automated antigenic assay of Fibrinogen The Framework Agreement is concluded with a minimum and a maximum Viral hepatitis C The Framework Agreement is concluded with a minimum and a maximum Radial immunodiffusion The Framework Agreement is concluded with a minimum and a maximum C1 Esterase inhibitor The Framework Agreement is concluded with a minimum and a maximum Hessian stain reagents for paraffin cuts The AgreementFramework is concluded with a minimum and a maximum Radioactive markers and revelation system The Framework Agreement is concluded with a minimum and a maximum Inclusion medium for frozen cuts The Framework Agreement is concluded with a minimum and a maximum Mounting medium The Framework Agreement is concluded with a minimum and a maximum Mounting medium for Pathology lamella gluer The Framework Agreement is concluded with a minimum and a maximum Mycology: culture medium (Sabouraud liquid medium tube of 10 ml) the framework agreement is concluded with a minimum and a maximum Mycology: culture medium (rpmi medium, petri dish diameter 90 mm) the framework agreement is concluded with a minimum and a maximum Mycology: chromogenic media Isolation of yeasts the framework agreement is concluded with a minimum and a maximum Mycology: Immunological REACTIF The framework agreement is concluded with a minimum and a maximum Mycology Media ready for use The Framework Agreement is concluded with a minimum and a maximum Separation medium for Lymphocytes The Framework Agreement is concluded with a minimum and a maximum Micro Diffuser The Framework Agreement is concluded with a minimum and a maximum Chemical products and diagnostic reagents (Sodium chloride for analysis acs iso (1 000 g) - tris(Hydroxymethyl)-Aminomethane (500 g)) The Framework Agreement is concluded with a minimum and maximum Dyes for Papanicolaou staining The Framework Agreement is concluded with a minimum and maximum Chemical products and diagnostic reagents (Nitric acid 65 % x 250 ml Suprapure - chloroform for analysis acs iso x 1 000 ml - dichloromethane for Lichrosolv chromatography x 2500 ml - diethyl ether Hypersol chromanorm x 2500 ml - ethyl acetate for Lichrosolv chromatography x 1 000 ml - methanol gradient Lichrosolv (1 000 ml) - n-Hexane for Lichrovolv chromatography x 1,000 ml - propan-2-ol for iso acs analysis (1,000 ml) The Framework Agreement is concluded with a minimum and maximum Dna staining on histological sections or cells The Framework Agreement is concluded with a minimum and maximum Chemical products for conventional techniques, Molecular Research and Biology The Framework Agreement is concluded with a minimum and a maximum Fixator for Cytodiagnosis The Framework Agreement is concluded with a minimum and a maximum Inclusion Product for Pathological Anatomy The Framework Agreement is concluded with a minimum and a maximum Virology: detection and quantification of the Ebv vrus The Framework Agreement is concluded with a minimum and a maximum Reagents for pathological anatomy The Framework Agreement is concluded with a minimum and a maximum Reagents for the determination of Urinary Oxalate The Framework Agreement is concluded with a minimum and a maximum Chemical products for classical techniques, research and molecular biology (Bovine Albuminia Fraction V x 100 g - b.C.I.P (5 Bromo 4 Chloro 3 Indolyl Phosphate) 500 mg - tween 20 100 ml - trypsin concentrated 10 times 25 g trysin pig / l, in Hanks 100 ml - dithiotretol (Dtt)) The Framework Agreement is concluded with a minimum and maximum chemical products for conventional techniques, research and molecular biology (Tris-Borate-Edta Buffer concentrated 10 times x 1 litre - lysostaphin per 1mg) the framework agreement is concluded with a minimum and maximum chemical products for conventional techniques, research and molecular biology (Formaldehyde solution for molecular biology 37% per 25 ml - dimethyl sulfoxide (Dmso) per 100 ml) the framework agreement is concluded with a minimum and maximum Reagent for detection of hcg in serum and in Urine The Framework Agreement is concluded with a minimum and maximum Reagents for the determination of four immunosuppressants in lc/ms/ms in whole blood including internal standards Deuteres L' Accord-Framework is concluded with a minimum and a maximum Immunochromatographic test for drug detection in Urine The Framework Agreement is concluded with a minimum and a maximum Bacterial transport medium The Framework Agreement is concluded with a minimum and a maximum Colour for routine automatic histotechnical technique The AgreementFramework is concluded with a minimum and a maximum Antihelicobacter Pilori antibodies The Framework Agreement is concluded with a minimum and a maximum Reagent for the slow and gentle decalcification of bone and medullar biopsies The Framework Agreement is concluded with a minimum and a maximum Reagent for the rapid decalcification of bones The Framework Agreement is concluded with a minimum and a maximum Reagent for Cryostat The AgreementFramework is concluded with a minimum and a maximum Reagents for rapid diagnosis of malaria The Framework Agreement is concluded with a minimum and a maximum Immunochromatographic rapid qualitative test for detection of co-proantigens allowing at least the distinction of ENTAMŒBA histolytica and if possible combined with the research of CRYPTOSPORIDIUM Sp The AgreementFramework is concluded with a minimum and a maximum Reagent allowing the detection of pcr inhibitors in real time (Ready-to-use reaction mixture for the search for inhibitors of extraction and amplification of parasitic or fungal dna during real-time PCR reactions in TAQMAN fluorophore Yellow dye technology imperative C374) The Accord-Framework is concluded with a minimum and a maximum Reagents for coloration and concentration of parasites in stool The Framework Agreement is concluded with a minimum and a maximum Reagents for blood testing in stool The Framework Agreement is concluded with a minimum and a maximum Reagents for parasitological and Mycological serodiagnostics The AgreementFramework is concluded with a minimum and a maximum Reagent allowing the detection of pcr inhibitors in real time (Ready-to-use reaction mixture for the detection of viral dna extraction and amplification inhibitors during real-time PCR reactions in Taqman technology) The Accord-Framework is concluded with a minimum and a maximum Reagents for electron microscopy techniques The Framework Agreement is concluded with a minimum and a maximum Research of antinuclear and cytoplasmic Auto-Antibodies by Immunodot The Framework Agreement is concluded with a minimum and a maximum Research of Antineural antibodies The Framework Agreement is concluded with a minimum and a maximum bacterial serology: Streptococcal diseases (Detection of antistreptodornase (Asd) antibodies x about 20 tests) the framework agreement is concluded with a minimum and a maximum Bacterial serology: streptococcal diseases (Screening test for ASLO by latex agglutination including control x about 50 to 100 tests) the framework agreement is concluded with a minimum and a maximum bacterial serology: Diagnosis of Brucellosis The Framework Agreement is concluded with a minimum and a maximum Bacterial Serology: diagnosis of syphilis (Box for detection by enzyme immunoassay of anti Treponema pallidum antibodies (total Ig) x 96 tests) the Framework Agreement is concluded with a minimum and a maximum Bacterial Serology: diagnosis of syphilis (VDRL anthrax 100 tests set) the framework agreement is concluded with a minimum and a maximum Bacterial serology: diagnosis of Staphylococcal diseases The framework agreement is concluded with a minimum and a maximum Bacterial serology: Rapid diagnosis of Infectious Mononucleosis The Framework Agreement is concluded with a minimum and maximum Reagents for culture and identification of urogenital mycoplasma (A7 Agar for identification of mycoplasma) the Framework Agreement is concluded with a minimum and maximum Reagents for culture and identification of urogenital mycoplasma (Kit for identification and differential titration, x 20 ml or x 20 tests - transport medium 40 x 2 ml) the framework agreement is concluded with a minimum and maximum bacterial serology: serodiagnosis of chlamydia, trachomatis and Psittaci infections The Framework Agreement is concluded with a minimum and maximum Bacterial Serology: serodiagnosis of cat claw disease The Framework Agreement is concluded with a minimum and maximum Bacterial Serology: serodiagnosis of mycoplasma pneumoniae infections The Framework Agreement is concluded with a minimum and a maximum Bacterial serology: serodiagnosis of legionella pneumophila infections The Framework Agreement is concluded with a minimum and a maximum Bacterial serology: serodiagnosis of chlamydia infections The Framework Agreement is concluded with a minimum and maximum elisa parasitic serology (Toxocariasis 48 or 96 tests C1716 - complementary positive toxocariasis control x 1 ml) the Framework Agreement is concluded with a minimum and maximum elisa parasitic serology (Human Elisa Echinococcosis parasitic serology reagent (granulosus and /Ou multilocularis) in 48 or 96 wells) the Framework Agreement is concluded with a minimum and maximum parasitic serology: Immunoblot The Framework Agreement is concluded with a minimum and a maximum Elisa parasitic serology (Amebiasis 48 or 96 tests - complementary positive control x 1 ml) the Framework Agreement is concluded with a minimum and a maximum Elisa parasitic serology (Trichinosis 48 or 96 tests - complementary positive control x 1 ml) the Framework Agreement is concluded with a minimum and a maximum Elisa parasitic serology (Schistosoma mansoni (bilharziosis) 48 or 96 tests - complementary positive control x 1 ml) the AgreementFramework is concluded with a minimum and a maximum Fungal Serology The Framework Agreement is concluded with a minimum and a maximum Rapid qualitative test for detection of Echinococcus Ac granulosus by Immunochromatography The Framework Agreement is concluded with a minimum and a maximum hiv western Blot Serology The AgreementFramework is concluded with a minimum and a maximum Serology hiv 1 + 2 Immunodot The Framework Agreement is concluded with a minimum and a maximum Serology hiv 1 + 2 + Ag p24 rapid detection combo The Framework Agreement is concluded with a minimum and a maximum Viral Serology: epstein-barr virus (Ebv) antibody assay The Framework Agreement is concluded with a minimum and maximum Viral Serology: serodiagnosis of parvovirus B19 Igg AND Igm diseases The Framework Agreement is concluded with a minimum and a maximum Anti-Hla Serum controls The Framework Agreement is concluded with a minimum and a maximum Buffers (PBS Buffer ph 7.2 ± 2 QSP 500ml or 1l powder, tablet or ready-to-use with a shelf life after regeneration or opening of 1 month minimum) the Framework Agreement is concluded with a minimum and a maximum Buffers (babs .Ph 8,95 ready for use 125 ml) the framework agreement is concluded with a minimum and maximum Activation Test of basophiles by Flow Cytometry The Framework Agreement is concluded with a minimum and maximum hla B27 research by molecular biology (Pcr-Ssp) The AgreementFramework is concluded with a minimum and a maximum Typing hla classes i and ii by Pcr technique The Framework Agreement is concluded with a minimum and a maximum Typing hla by Microlymphocytotoxicity technique The Framework Agreement is concluded with a minimum and a maximum Typing hla by Ssp technique The Framework Agreement is concluded with a minimum and a maximum Virology: Human cells (Mrc5) for Viral Culture The Framework Agreement is concluded with a minimum and maximum Virology: Rapid detection of influenza virus antigens (Influenza) The Framework Agreement is concluded with a minimum and a maximum Virology: rapid research by rapid technique of specific igm hantaan Virus The Framework Agreement is concluded with a minimum and a maximum Virology: qualitative research of Norovirus The Framework Agreement is concluded with a minimum and a maximum Virology: reagents for diagnosis of herpes Viruses The Framework Agreement is concluded with a minimum and a maximum Virology: rapid detection of adenovirus and rotavirus antigens in stool in unit test The Framework Agreement is concluded with a minimum and a maximum Virology: rapid detection test on V membrane.ALL CLEAR. The Framework Agreement is concluded with a minimum and a maximum Virology: detection and quantification of parvovirus B19 The Framework Agreement is concluded with a minimum and a maximum Virology: detection and quantification of bk virus in biological fluids The Framework Agreement is concluded with a minimum and a maximum Virology: detection and quantification of Cytomegalovirus The Framework Agreement is concluded with a minimum and a maximum Antibodies for protein research 14/3/3/3 the Framework Agreement is concluded with a minimum and a maximum Reagents for protein research 14-3-3 the Framework Agreement is concluded with a minimum and a maximum Reagents for determination by elisa technique: - beta amyloid peptide 1-42 - tau protein - tau phosphorylee protein - beta amyloid peptide 1-40 the framework agreement is concluded with a minimum and a maximum Bacterial and viral respiratory infection research the framework agreement is concluded with a minimum and a maximum reagents for the determination of the acylcarnitine profile by lc-ms/ms from dry blood samples (Guthrie carton) the agreementFramework is concluded with a minimum and a maximum Reagent for the determination of plasma homocysteine by Lc-Ms/Ms The Framework Agreement is concluded with a minimum and a maximum Research of anti-islet antibodies of langerhans by indirect immunofluorescence The Framework Agreement is concluded with a minimum and a maximum Reagents and consumables for icp/ms Nexion 300q (PVC pump tube diameter 0.38 mm orange and green x 12 - stop tube for peristaltic pump diameter 1.30mm grey x 12 - stop tube for peristaltic pump diameter 1.14 mm red/red/red/red x 12) the framework agreement is concluded with a minimum and maximum Reagents and consumables for Starrsed Systèmes Inversa 24m the framework agreement is concluded with a minimum and maximum Reagents for taz 19 chemical hood MANUFACTURER The framework agreement is concluded with a minimum and maximum molecular biology: hla sequencing reagents by Ngs The Framework Agreement is concluded with a minimum and a maximum Molecular Biology: reagent kit and analysis for the identification of myeloid gene mutations (lam, smd and SMP outside Lmc) and Lymphoid (Llc) The Framework Agreement is concluded with a minimum and a maximum Molecular Biology: LIBRARY preparation kit by Capture The Framework Agreement is concluded with a minimum and a maximum Monolight probe for onco-hematology Tp53/Atm The Framework Agreement is concluded with a minimum and a maximum Myc probe with signal separation ("Break Apart") and information on the coverage/size area of the region framed by the probes 5'/3' the agreementframework is concluded with a minimum and a maximum Monolocus probe for onco-hematology Mll/Kmt2a The Framework Agreement is concluded with a minimum and a maximum Monolocus probe for onco-hematology Tp53 The Framework Agreement is concluded with a minimum and a maximum
- Opportunity closing date
- 08 April 2019
- Value of contract
- £5m-50m
About the buyer
- Address
- CHU Reims 45 rue Cognacq-Jay Reims Cedex Cellule-des-Marchés Publics 51092 France
- Contact
- cellulemarches@chu-reims.fr
The deadline to apply for this opportunity has passed.
Visit the
opportunities page
to find another.